CrowdStrike Stock Plunges 13% in a Month: Time to Hold or Exit?

CrowdStrike (CRWD) stock has underperformed, plunging 12.6% over the past month, driven by concerns over its premium valuation, decelerating revenue growth, and profitability compression. The company's forward P/S ratio of 21.38X significantly exceeds the industry average, while revenue growth has slowed from 35% in FY24 to a projected 21% by FY27. Furthermore, Q1 FY26 non-GAAP EPS declined 7.6% year-over-year due to rising R&D and sales & marketing expenses, leading analysts to rate CRWD as a 'Sell' due to its reduced near-term attractiveness.

Analysis

CrowdStrike (CRWD) is facing significant headwinds, reflected in its recent 12.6% stock price decline over the past month, underperforming both the Zacks Security industry and key peers like CyberArk and Zscaler. The core issues are threefold: a premium valuation, decelerating growth, and compressing profitability. CRWD trades at a forward 12-month price-to-sales (P/S) multiple of 21.38x, substantially higher than the industry average of 12.56x and peers such as CYBR (13.75x) and ZS (13.74x). This valuation is increasingly difficult to justify as the company's top-line growth is slowing, having decelerated from over 35% in fiscal 2024 to an estimated 29% in fiscal 2025, with projections for further deceleration to approximately 21% by fiscal 2027. Concurrently, profitability is under pressure from aggressive spending. In the first quarter of fiscal 2026, research & development and sales & marketing expenses surged 34.7% and 25.5% year-over-year, respectively, contributing to a 7.6% decline in non-GAAP EPS. This combination of a rich valuation unsupported by slowing fundamentals presents a challenging near-term outlook for the stock.

Key Decisions for Investors

• Given the stock's premium valuation relative to peers and its own slowing growth trajectory, investors should reassess exposure to CRWD as it appears vulnerable to further multiple contraction.
• Monitor future earnings reports closely for any stabilization in revenue growth and, more critically, for evidence of operating leverage where profit margins improve despite continued high investment in R&D and sales.
• Consider rotating capital into more attractively valued cybersecurity peers mentioned, such as CyberArk (CYBR), which has demonstrated relative price strength and trades at a significantly lower P/S multiple.